Medical School - University of Vermont College of Medicine, Burlington, VT
Residency - Duke University Medical Center, Durham, NC
Fellowship - William Beaumont Hospital, Royal Oak, MI
Medtronic CoreValve® U.S. Pivotal Trial
Renal Denervation in Patients with Uncontrolled Hypertension (SYMPLICITY HTN-3)
Evaluation of XIENCE Prime™ or XIENCE V versus Coronary Artery Bypass Surgery for effectiveness of left main revascularization
Cangrelor versus standard therapy to achieve optimal management of platelet inhibition
OMEGA- A Prospective, Multicenter, Single-Arm trial at assess the OMEGA™ Coronary Stent System for the treatment of a single De Novo Coronary Artery Lesion
Evaluation of Sodium Bicarbonate to Reduce Contrast-Induced Chronic Kidney Injury in Subjects with Advanced Chronic Kidney Disease (DKD) who are Undergoing Angiography
Endeavor Drug Eluting Stenting: Understanding Care, Antiplatelet Agents and Thrombotic Events. (EDUCATE)
A Clinical Evaluation of the Medtronic Endeavor® Resolute Zotarolimus- eluting coronary stent system in the treatment of De Novo lesions in Native Coronary Arteries with a reference vessel diameter of 2.25mm to 4.2mm.
A Clinical Evaluation of the XIENCE PRIME and XIENCE PRIME LL Everolimus Eluting coronary Stent system.
Terrien E, Schneider D, Gogo P, Sobel B, Dauerman H. Osteoprotegerin is Not Associated with Angiographic Coronary Calcification. Journal of Thrombosis and Thrombolysis.
Terrien E, Schneider D, Watkins M, Gogo P, Sobel B, Dauerman H. Systemic Inflammation After Drug-Eluting Stent Placement. Journal of Thrombosis and Thrombolysis. 2005 Apr;19(2):87-92.
Terrien E, Schneider D, Gogo P, Watkins M, Sobel B, Dauerman H. Relation of Leukocytosis to C-Reactive Protein and Interluekin-6 Among Patients Undergoing Percutaneous Coronary Intervention. American Journal of Cardiology. 2005 Aug 15;96(4):538-42.